Look this up using: the FDA approved "Prescribing Information" summary: http://www.janssencns.com/shared/product/invegasustenna/prescribing-information.pdf. The PI is the minimum information which the FDA thinks any physician should have in order to decide if the product might be useful to prescribe for a patient. Yet, who has the most vested interest in this information? The person who is considering/taking it.
Answered 7/5/2015
2.6k views
Yes: Invega Sustenna (paliperidone palmitate) is sustained release formulation of Paliperidone. Paliperidone is active metabolite of risperidone, a common atypical antipsychotic med indicated for schizophrenia and othe off-label uses. 3mg/day is considered on the low dose end of the spectrum with 12mg/day considered max dose. It also comes in long acting injectable form which has been associated with some fatalities.
Answered 7/12/2015
2.6k views
Yes: Invega Sustenna (paliperidone palmitate) (monthly injectable form) ranges from 39mg - 234mg per month. the tablet form of invega ranges from 1-12mg daily
Answered 5/1/2016
2.6k views
A doctor has provided 1 answer
A doctor has provided 1 answer
A doctor has provided 1 answer
A doctor has provided 1 answer
A doctor has provided 1 answer
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question